F3 Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$17 Million
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-09-11 16:58

Core Viewpoint - F3 Uranium Corp. has announced an increase in its private placement offering from C$15 million to C$17 million due to strong investor demand [2]. Group 1: Offering Details - The offering consists of Units and Flow-Through (FT) Units, with each Unit comprising one common share and one-half of a warrant [4]. - The FT Units will be issued as flow-through shares, qualifying for tax benefits under Canadian regulations [4]. - The lead underwriter for the offering is Red Cloud Securities Inc., which has an option to purchase additional units for up to C$3 million in gross proceeds [5]. Group 2: Use of Proceeds - Proceeds from the offering will be allocated to fund exploration projects in the Athabasca Basin and for general corporate purposes [6]. - The gross proceeds from FT Shares will be used to incur eligible Canadian exploration expenses related to uranium projects [7]. Group 3: Offering Structure - The offering includes 25 million units at a price of C$0.20 per Unit, 23.33 million federal flow-through units at C$0.30 each, and 15.15 million Saskatchewan flow-through units at C$0.33 each [8]. - The offering is scheduled to close on October 1, 2025, subject to regulatory approvals [12]. Group 4: Company Overview - F3 Uranium Corp. focuses on uranium exploration, particularly in the high-grade JR Zone and Tetra Zone in the Athabasca Basin, which is known for significant uranium deposits [14].